Drugs / Provacel
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00114452 Comparator | Mar 2005 → Oct 2006 | myocardial infarction | Mesoblast, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Provacel | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00114452 ↗ |
| Known as | PUMP1 | “adult stem cells \[Provacel™(PUMP1)\] are safe and possibly effective in the treatment of acute myocardial infarction (heart attack).” NCT00114452 ↗ |
| Modality | Cell therapy | “intravenous allogeneic human mesenchymal stem cells (hMSCs)” PMID 19958962 ↗ Dec 2009 |
| Route | Intravenous | “intravenous allogeneic human mesenchymal stem cells (hMSCs)” PMID 19958962 ↗ Dec 2009 |